## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r
β¦ LIBER β¦
178 oral Ototoxicity in targeted supradose cisplatin chemoradiation in irresectable squamous cell carcinoma of the head and neck
- Book ID
- 119515657
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 130 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0167-8140
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Targeted therapies in squamous cell carc
β
Kathryn A. Gold; Ho-Young Lee; Edward S. Kim
π
Article
π
2009
π
John Wiley and Sons
π
English
β 170 KB
π 3 views
Molecular markers predict outcome in squ
β
Guido B. van den Broek; Maarten Wildeman; Coen R.N. Rasch; Nicola Armstrong; Ed
π
Article
π
2009
π
John Wiley and Sons
π
French
β 141 KB
π 1 views
## Abstract Not all patients with squamous cell carcinomas of the head and neck (HNSCC) benefit from concurrent cisplatinβbased chemoradiation, but reliable predictive markers for outcome after chemoradiation are scarce. We have investigated potential prognostic biomarkers for outcome in a large gr
Molecular Targets in Squamous Cell Carci
β
Keisuke Shirai; Paul E. OβBrien
π
Article
π
2007
π
Springer
π
English
β 197 KB
Novel therapeutic targets in squamous ce
β
Ezra E.W. Cohen
π
Article
π
2004
π
Elsevier Science
π
English
β 348 KB
Squamous cell carcinoma radioimmunoassay
β
David W. Cook; Thomas Winek; Harvey Baker; Clifford W. Deveney; Truman Sasaki
π
Article
π
1989
π
Elsevier Science
π
English
β 264 KB
Identification of cisplatin-resistance r
β
Yukio Yamano; Katsuhiro Uzawa; Kengo Saito; Dai Nakashima; Atsushi Kasamatsu; Hi
π
Article
π
2010
π
John Wiley and Sons
π
French
β 355 KB
π 2 views
## Abstract Resistance to cisplatin is a major obstacle to successful treatment of head and neck squamous cell carcinoma (HNSCC). To investigate the molecular mechanism of this resistance, we compared the gene expression profiles between the cisplatinβsensitive SCC cell lines (Saβ3, Hβ1 and KB) and